Moreover, in a study, it was reported that methylation of the PXR promoter modulated the mRNA expression of PXR and CYP3A4 in CRC cell lines, suggesting the involvement of PXR/CYP3A4 axis during colon carcinogenesis and drug responses. Here, CYP3A4 is linked to colorectal carcinoma.